$7.18
-0.03[-0.42%]
Last update: 9:30AM Get Real Time Here
Replimune Group
(NASDAQ:REPL)Replimune Group Stock (NASDAQ:REPL), Quotes and News Summary
Replimune Group Stock (NASDAQ: REPL) stock price, news, charts, stock research, profile.
| Open | $7.200 |
| Close | - |
| Volume / Avg. | 457.654K / 1.338M |
| Day Range | 7.050 - 7.430 |
| 52 Wk Range | 5.890 - 24.810 |
| Market Cap | $440.764M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 40 |
| Short Interest | 14.37% |
| Days to Cover | 7.74 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Replimune Group Inc
Sector
Health Care
Industry
Biotechnology
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Replimune Group (REPL) stock?
You can purchase shares of Replimune Group (NASDAQ: REPL) through any online brokerage.
Who are Replimune Group's (REPL) competitors?
Other companies in Replimune Group’s space includes: Skye Bioscience (NASDAQ:SKYE), KalVista Pharma (NASDAQ:KALV), Voyager Therapeutics (NASDAQ:VYGR), Larimar Therapeutics (NASDAQ:LRMR) and CareDx (NASDAQ:CDNA).
What is the target price for Replimune Group (REPL) stock?
The latest price target for Replimune Group (NASDAQ: REPL) was reported by Barclays on Wednesday, December 6, 2023. The analyst firm set a price target for 13.00 expecting REPL to rise to within 12 months (a possible 81.06% upside). 13 analyst firms have reported ratings in the last year.
Current Stock Price for Replimune Group (REPL)?
The stock price for Replimune Group (NASDAQ: REPL) is $7.18 last updated Today at April 18, 2024 at 9:30 AM EDT.
Does Replimune Group (REPL) pay a dividend?
There are no upcoming dividends for Replimune Group.
When is Replimune Group (NASDAQ:REPL) reporting earnings?
Replimune Group’s Q4 earnings are confirmed for Thursday, May 16, 2024.
Is Replimune Group (REPL) going to split?
There is no upcoming split for Replimune Group.
What sector and industry does Replimune Group (REPL) operate in?
Replimune Group is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.